Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.000p
   
  • Closing Price Chg:
    -1.00p
  • 52 Week High: 0.000p
  • 52 Week Low: 0.000p
  • Currency: UK Pounds
  • Shares Issued: 502.72m
  • Volume: 0
  • RiskGrade: 328

Deal with Barclays    Trade now with Barclays Stockbrokers

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
16-Apr-18 Berenberg Bank Buy 147.00p 1,200.00p 1,200.00p Reiteration
23-Mar-18 Northland Capital Partners Buy 125.50p - 181.00p Reiteration
21-Dec-17 FinnCap Buy 150.00p 237.00p 237.00p Reiteration
21-Sep-17 Northland Capital Partners Buy 50.50p - 181.00p Reiteration
20-Jul-16 Northland Capital Partners Buy 37.00p - 171.00p New Coverage
30-Apr-15 Panmure Gordon Buy - 150.00p 150.00p Reiteration
21-Oct-14 Panmure Gordon Buy - 150.00p 150.00p Reiteration
09-Oct-14 Panmure Gordon Buy - 150.00p 150.00p Reiteration
27-Sep-13 Panmure Gordon Buy - 150.00p 150.00p Reiteration
19-Sep-13 Panmure Gordon Buy - 150.00p 150.00p Reiteration
09-Jul-13 Panmure Gordon Buy - 150.00p 150.00p Reiteration
21-May-13 Panmure Gordon Buy - 150.00p 150.00p Reiteration
09-Apr-13 Panmure Gordon Buy - 150.00p 150.00p Reiteration
15-Nov-12 Panmure Gordon Buy - 150.00p 150.00p Reiteration
21-Sep-12 Panmure Gordon Buy - 150.00p - Reiteration
02-Apr-12 Panmure Gordon Buy - 150.00p - Reiteration
23-Mar-12 Panmure Gordon Buy - 150.00p - Reiteration
12-Mar-12 Peel Hunt Limited Sell - - 50.00p New Coverage
21-Nov-11 Sanlam Securities Buy - - 323.00p New Coverage
03-Nov-11 Panmure Gordon Buy - 150.00p - Reiteration
21-Oct-11 Panmure Gordon Buy - 150.00p - Reiteration
29-Sep-11 Panmure Gordon Buy - 150.00p - Reiteration
03-Aug-11 Panmure Gordon Buy - 150.00p - Reiteration
03-May-11 Panmure Gordon Buy - 80.00p 150.00p Upgrade
04-Apr-11 Panmure Gordon Hold - 80.00p - Reiteration
31-Mar-11 Panmure Gordon Hold - - - DownGrade
22-Mar-11 Panmure Gordon Buy - 300.00p - Reiteration
21-Feb-11 Panmure Gordon Buy - 300.00p - Reiteration
27-Jan-11 Panmure Gordon Buy - 300.00p - Reiteration
06-Dec-10 Espirito Santo Execution Buy - 200.00p - Reiteration
17-Nov-10 Panmure Gordon Buy - 300.00p - Reiteration
30-Sep-10 Panmure Gordon Buy - 300.00p - Reiteration
30-Sep-10 Singer Capital Markets Buy - - - Reiteration
22-Jun-10 Panmure Gordon Buy - 300.00p - Reiteration
19-May-10 Panmure Gordon Buy - 300.00p - Reiteration
26-Apr-10 Panmure Gordon Buy - 300.00p - Reiteration
02-Dec-09 Panmure Gordon Buy - 300.00p - Reiteration
12-Nov-09 Panmure Gordon Buy - 300.00p - Reiteration
21-Oct-09 Panmure Gordon Buy - 300.00p - Reiteration
29-Sep-09 Panmure Gordon Buy - 300.00p - Reiteration
12-Mar-09 Panmure Gordon Buy - 234.00p 300.00p Reiteration
30-Jan-09 Panmure Gordon Buy - 234.00p - Reiteration
23-Dec-08 Panmure Gordon Buy - 234.00p - Reiteration
25-Nov-08 Panmure Gordon Buy - 194.00p 234.00p Reiteration
12-Nov-08 Panmure Gordon Buy - 194.00p - Reiteration
25-Sep-08 Panmure Gordon Buy - 194.00p - Reiteration
20-May-08 Panmure Gordon Buy - 194.00p - Reiteration
01-May-08 Panmure Gordon Buy - 194.00p - Reiteration
26-Feb-08 Panmure Gordon Buy - 194.00p - Reiteration
08-Jan-08 Panmure Gordon Buy - 194.00p - Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Immupharma Market Data

Currency UK Pounds
Share Price 10.00p
Closing Price Change -1.00p
% Change 0.00 %
52 Week High 0.000p
52 Week Low 0.000p
Volume 0
Shares Issued 502.72m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page